These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 308921)

  • 21. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease.
    Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M
    J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hodgkin disease--pathogenesis and therapy].
    Wolf J; Diehl V
    Ther Umsch; 1996 Feb; 53(2):140-6. PubMed ID: 8629264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in human lymphocyte subpopulation in Hodgkin's lymphoma.
    Rejthar A; Patera J; Rejtharová A; Hrdlicková N
    Neoplasma; 1976; 23(4):371-5. PubMed ID: 1087377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Johansson B
    Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
    Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
    Milosević D; Marinković M; Colović M; Jelić S
    Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment in cellular protein phosphorylation by mitogen activated lymphocytes from patients with Hodgkin's disease.
    Damle RN; Gangal SG; Advani SH
    Indian J Med Res; 1992 Aug; 96():230-5. PubMed ID: 1428061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-lymphocytes bearing Fc-receptors for IgG in B-cell chronic lymphocytic leukaemia.
    Matolcsy A; Magyarlaki T; Baliko Z; Tornoczky J
    Haematologia (Budap); 1985; 18(3):185-91. PubMed ID: 2941348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Granulocyte adherence in advanced Hodgkin's disease and its dependence on antiproliferative drugs used].
    Hansz J; Prazmowska-Owczarek B; Nowicka G
    Acta Haematol Pol; 1979; 10(1):7-12. PubMed ID: 373364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiotherapy of lymphogranulomatosis in adulthood].
    Dühmke E
    Praxis (Bern 1994); 1996 Mar; 85(12):371-7. PubMed ID: 8643900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphocyte response to phytohemagglutinin-stimulation after extended radiation therapy in Hodgkin's disease (author's transl)].
    Krüsmann W; Slanina J; Vorwerck H
    Strahlentherapie; 1979 Jun; 155(6):416-8. PubMed ID: 111376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z; Strober S; King DP; Kaplan HS
    J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.